These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 29704685)
21. Application of next-generation sequencing technology in forensic science. Yang Y; Xie B; Yan J Genomics Proteomics Bioinformatics; 2014 Oct; 12(5):190-7. PubMed ID: 25462152 [TBL] [Abstract][Full Text] [Related]
22. [Towards a national standardisation of NGS studies in the diagnosis of myopathies]. Krahn M; Cerino M; Campana-Salort E; Cossée M Med Sci (Paris); 2017 Nov; 33 Hors série n°1():30-33. PubMed ID: 29139383 [No Abstract] [Full Text] [Related]
23. Next generation sequencing--implications for clinical practice. Raffan E; Semple RK Br Med Bull; 2011; 99():53-71. PubMed ID: 21705347 [TBL] [Abstract][Full Text] [Related]
24. Clinical application of next-generation sequencing for Mendelian diseases. Jamuar SS; Tan EC Hum Genomics; 2015 Jun; 9(1):10. PubMed ID: 26076878 [TBL] [Abstract][Full Text] [Related]
25. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment. Burris HA; Saltz LB; Yu PP Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307 [TBL] [Abstract][Full Text] [Related]
26. Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome. Gallego CJ; Perez ML; Burt A; Amendola LM; Shirts BH; Pritchard CC; Hisama FM; Bennett RL; Veenstra DL; Jarvik GP J Genet Couns; 2016 Jun; 25(3):515-9. PubMed ID: 26637299 [TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing and its applications in molecular diagnostics. Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242 [TBL] [Abstract][Full Text] [Related]
28. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850 [TBL] [Abstract][Full Text] [Related]
30. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318 [TBL] [Abstract][Full Text] [Related]
31. Translational utility of next-generation sequencing. Ong FS; Lin JC; Das K; Grosu DS; Fan JB Genomics; 2013 Sep; 102(3):137-9. PubMed ID: 23631825 [TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing for MicroRNA Expression Profile. Hu Y; Lan W; Miller D Methods Mol Biol; 2017; 1617():169-177. PubMed ID: 28540684 [TBL] [Abstract][Full Text] [Related]
33. Managing the ethical challenges of next-generation sequencing in genomic medicine. Clarke AJ Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627 [TBL] [Abstract][Full Text] [Related]
34. Clinical validation of targeted next-generation sequencing for inherited disorders. Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102 [TBL] [Abstract][Full Text] [Related]
35. NGS-Based genetic testing for heritable cardiovascular diseases. Specific requirements for obtaining informed consent. Schmidtke J; Wittkowski K; Glaubitz R Mol Cell Probes; 2019 Jun; 45():70-78. PubMed ID: 31059777 [TBL] [Abstract][Full Text] [Related]
36. Next generation sequencing: implications in personalized medicine and pharmacogenomics. Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891 [TBL] [Abstract][Full Text] [Related]
37. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis. Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475 [TBL] [Abstract][Full Text] [Related]
38. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing. Mu W; Lu HM; Chen J; Li S; Elliott AM J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647 [TBL] [Abstract][Full Text] [Related]
39. The virtuous technology cycle concept and its application in next-generation sequencing. Pluess-Li Y; Bongiovanni S; Oakeley EJ; Johnson KJ; Staedtler F Drug Discov Today; 2012 Sep; 17(17-18):1015-22. PubMed ID: 22521661 [TBL] [Abstract][Full Text] [Related]
40. Systematic review of next-generation sequencing simulators: computational tools, features and perspectives. Zhao M; Liu D; Qu H Brief Funct Genomics; 2017 May; 16(3):121-128. PubMed ID: 27069250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]